GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jinhe Biotechnology Co Ltd (SZSE:002688) » Definitions » Additional Paid-In Capital

Jinhe Biotechnology Co (SZSE:002688) Additional Paid-In Capital : ¥0 Mil(As of Mar. 2024)


View and export this data going back to 2012. Start your Free Trial

What is Jinhe Biotechnology Co Additional Paid-In Capital?


Jinhe Biotechnology Co's quarterly additional paid-in capital increased from Sep. 2023 (¥0 Mil) to Dec. 2023 (¥868 Mil) but then stayed the same from Dec. 2023 (¥868 Mil) to Mar. 2024 (¥0 Mil).

Jinhe Biotechnology Co's annual additional paid-in capital declined from Dec. 2021 (¥1,058 Mil) to Dec. 2022 (¥868 Mil) but then stayed the same from Dec. 2022 (¥868 Mil) to Dec. 2023 (¥868 Mil).


Jinhe Biotechnology Co Additional Paid-In Capital Historical Data

The historical data trend for Jinhe Biotechnology Co's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jinhe Biotechnology Co Additional Paid-In Capital Chart

Jinhe Biotechnology Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Additional Paid-In Capital
Get a 7-Day Free Trial Premium Member Only Premium Member Only 401.58 401.15 1,058.26 868.18 868.18

Jinhe Biotechnology Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 868.18 - 868.18 -

Jinhe Biotechnology Co Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Jinhe Biotechnology Co Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Jinhe Biotechnology Co's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


Jinhe Biotechnology Co (SZSE:002688) Business Description

Traded in Other Exchanges
N/A
Address
Zone B3 Xinghai Plaza, 1-7-2 Building 27, Shahekou District, Dalian, CHN, 116023
Jinhe Biotechnology Co Ltd is engaged in manufacturing veterinary feed additives, veterinary vaccines, veterinary chemicals, corn starch processing and industrial wastewater treatment business.
Executives
Wang Zhi Jun Directors, executives
Liu Ying Chun Executives
Deng Yi Xin Secretary Dong
Li Fu Zhong Director
Liu Yun Tian Directors, executives
Xie Chang Xian Directors, executives
Wang Dong Xiao Director
Yao Jian Xiong Supervisors
Zheng Liu Ji Supervisors
Niu You Shan Executives
Wu Ming Xia Director
Li Wei Qi Directors, executives
Wu Rui Gang Executives

Jinhe Biotechnology Co (SZSE:002688) Headlines

No Headlines